March 18, 2026 - Today Diabetes Canada launched Aprons in Action presented by Manulife, a first-of-its-kind national cooking ...

Toronto, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the lives of people living with, or ...

Ozempic ® is indicated as an adjunct to diet, exercise, and standard of care to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or ...

Dexcom G7 is the most accurate CGM system1 approved by Health Canada, building on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hypoglycemia, and improve time ...

Canada can build successful diabetes prevention and remission programs across the country by learning from England, a Quebec-based team of clinician-scientists and other experts suggested. England’s ...

Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes. The FreeStyle Libre 2 system continuously ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

WASHINGTON (Reuters) - Rates of diabetes in Canada's most populous province have already zoomed past what was predicted for 2030, which suggests the global epidemic will be far worse than feared, ...

Dexcom G7 is available for people with all types of diabetes ages two years and older, giving more Canadians than ever access to a simple, accurate 1 and effective diabetes management solution BURNABY ...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada ...

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.